Skip to main content
. Author manuscript; available in PMC: 2012 Mar 15.
Published in final edited form as: Vaccine. 2010 Jul 12;28(31):4997–5004. doi: 10.1016/j.vaccine.2010.05.023

Table 1. A single immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L elicits complete protection against a virulent respiratory poxvirus infection.

A33R Forward 5′- CACCGGATCCATGATGACACCAGAAAACGACGAAG -3′ (BamHI)
Reverse 5′- GAATTCTTAGTTCATTGTTTTAACAC -3′ (EcoRI)
A34R Forward 5′- CACCGGATCCATGAAATCGCTTAATAGACAAACTG -3′ (BamHI)
Reverse 5′- GAATTCTCACTTGTAGAATTTTTTAACAC -3′ (EcoRI)
A36R Forward 5′- CACCGGATCCATGATGCTGGTACCTCTTATCACG -3′ (BamHI)
Reverse 5′- GAATTCTCACACCAATGATACGACCGATG -3′ (EcoRI)
B5R Forward 5′- CACCAGATCTATGAAAACGATTTCCGTTGTTACG -3′ (BgIII)
Reverse 5′- CTGCAGTTACGGTAGCAATTTATGGAAC -3′ (PstI)
A27L Forward 5′- CACCATGGGATCCATGGACGGAACTC -3′ (BamHI)
Reverse 5′- GAATTCTTACTCATATGGACGCCGTC -3′ (EcoRI)
L1R Forward 5′- CACCATGGGATCCATGGGTGCCGCAC -3′ (BamHI)
Reverse 5′- GAATTCTCAGTTTTGCATATCCGTGG -3′ (EcoRI)

Primer sequences for the vaccinia virus proteins used for PCR amplification with highlighted “CACC” sequences and underlined restriction enzyme sites